molecules of the month


oral, first-in-class CHIT1/AMCase chitinase inh.

for sarcoidosis/lung fibrosis, Ph. Ib complete

from opt. of literature molecule

J. Med. Chem., Oct. 20, 2020

OncoArendi Therapeutics SA, Warsaw, PL

Structure of molecule OATD-01
1 min read

OATD-01 (OncoArendi Therapeutics oral, first-in-class CHIT1/AMCase chitinase inhibitor clinical candidate)

request a trial

You don’t have time to read everything, but you can’t afford to fall behind.

Drug Hunter Premium is drug discovery, distilled, so you can quickly catch up and make informed decisions based on industry examples.

Get ahead now by requesting a trial.

already a member? log in: